Edit |   |
---|---|
Antigenic Specificity | TNF alpha (Infliximab biosimilar) |
Clone | monoclonal |
Host Species | Humanized |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified, low endotoxin |
Size | 1mg |
Concentration | 1.0 - 5.0 mg/ml |
Applications | RUO |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: detects human TNF-alpha. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Infliximab. Infliximab biosimilar is a chimeric IgG1κ monoclonal antibody (composed of human constant and murine variable regions) specific for human tumor necrosis factor-alpha (TNFα). It has a molecular weight of approximately 149.1 kilodaltons. Infliximab biosimilar is produced by a recombinant cell line cultured by suspension culture and is purified by a series of steps that includes measures to inactivate and remove viruses. |
Immunogen | n/a |
Other Names | Cachectin, TNFa, Tumor necrosis factor ligand superfamily member 2, Tnfsf2 |
Gene, Accession # | UniProt: P01375 |
Catalog # | ICH4006-1mg |
Price | $300 |
Order / More Info | TNF alpha (Infliximab biosimilar) Antibody from ICHORBIO |
Product Specific References | n/a |
U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio